Keyphrases
Liquid Chromatography-high Resolution Mass Spectrometry (LC-HRMS)
100%
New Psychoactive Substances
79%
Wastewater
74%
Synthetic Cannabinoids
73%
Metabolism
63%
Human Hepatocytes
63%
MS-MS
38%
Rat Hepatocytes
38%
Ultra-high Performance Liquid Chromatography (UHPLC)
36%
Pseudomonas Putida
36%
Microbial Biotransformation
36%
In Vitro Metabolism
36%
Incubation
31%
Metabolic Profiling
28%
Illicit Drugs
28%
Screening Method
28%
Hydroxylation
28%
Human Urine
25%
Retention Time
23%
Whole Blood
22%
Time-of-flight Mass Spectrometry
22%
Synthetic Cannabinoid Receptor Agonists
21%
Forensic Samples
21%
Phase I Metabolism
21%
Biological Samples
21%
Cytochrome P450 Enzymes
21%
Plasma Protein Binding
20%
Toxicokinetics
20%
Mass Spectrometry Methods
20%
Wastewater-based Epidemiology
20%
Biomarker Selection
18%
Bromo-dragonFLY
18%
Electrospray Ionization
18%
Human Exposure
18%
Mass Spectrometry Data
18%
UHPLC-HRMS
18%
Soil Samples
18%
Halogenated Analogues
18%
Comprehensive Investigation
18%
3,4-methylenedioxymethamphetamine
18%
Positive Electrospray Ionization
18%
WIN55,212-2
18%
Lysergic Acid Diethylamide
18%
Pyrrolidinone
18%
Cocaine
18%
Reversed-phase HPLC
18%
JWH-122
18%
Retrospective Analysis
18%
Ion Mobility
18%
Denmark
18%
Chemistry
Metabolite
68%
Illicit Drug
54%
Synthetic Cannabinoid
54%
High Resolution Mass Spectrometry (HRMS)
45%
Metabolic
44%
stability
40%
Mass Spectrometry
36%
Retention Time
29%
Drug Screening
24%
Liquid Chromatography
23%
Biological Marker
21%
High-Pressure Liquid Chromatography
20%
Lysergic Acid Diethylamide
18%
Valproate
18%
Binding Protein
18%
Ion Mobility
18%
Matrix-Assisted Laser Desorption-Ionization
18%
Toxicokinetics
18%
Ion Mobility Spectroscopy
18%
Reverse Phase Liquid Chromatography
18%
Ultra Performance Liquid Chromatography
18%
Mephedrone
18%
3,4-methylenedioxymethamphetamine
18%
Tandem Mass Spectrometry
18%
hydroxylation
16%
Solid-Phase Extraction
15%
Pharmacology, Toxicology and Pharmaceutical Science
Illegal Drug
63%
Cannabinoid
54%
Ultra High Performance Liquid Chromatography
40%
Glucuronide
39%
Toxicokinetics
27%
Toxic Injury
24%
Plasma Protein Binding
21%
Cannabinoid Receptor Agonist
21%
Pseudomonas putida
18%
Tamsulosin
18%
Glutathione
18%
Phenmetrazine
18%
Effusion
18%
Electrospray Ionization
18%
Lysergide
18%
Amine Oxidase (Flavin Containing) Isoenzyme A
18%
Sodium Valproate
18%
WIN 55,212-2
18%
Biological Marker
18%
Cytochrome P450
18%
Methylenedioxypyrovalerone
18%
Fentanyl Derivative
18%
N Ethyl 3,4 Methylenedioxyamphetamine
18%
Intrinsic Clearance
18%
CYP3A4
18%
Mephedrone
18%